The key component, HDCA, of PBP exerts therapeutic effects by inhibiting Ras-related nuclear protein (RAN)-mediated peroxisome proliferator-activated receptor alpha (PPAR) nuclear transport, enhancing PPAR nuclear localization, and activating PPAR-dependent fatty acid oxidation, thus alleviating MASLD (Kuang et al., 2023)
Dorman, S
Heres what I want you to know: its not your fault
[1] Tirzepatide (Mounjaro, Zepbound) has a half-life of approximately 5 days, with elimination taking about 4-5 weeks after the last dose
Karsdal (Nordic Biosciences, Denmark) for assistance with circulating collagen fragment detection and interpretation
Challenges with peptide-based therapies for back pain To probe whether this peptide might be used as a drug therapy to delay or prevent degeneration, the team treated mice with the peptide for four consecutive weeks